# Fluorouracil and Biological Therapy in Treating Patients With Metastatic Kidney or Colorectal Cancer

> **NCT00016042** · PHASE1 · UNKNOWN · sponsor: **St. Luke's Medical Center**

## Conditions studied

- Colorectal Cancer
- Kidney Cancer

## Interventions

- **BIOLOGICAL:** lymphokine-activated killer cells
- **BIOLOGICAL:** recombinant interferon alfa
- **BIOLOGICAL:** sargramostim
- **DRUG:** fluorouracil

## Key facts

- **NCT ID:** NCT00016042
- **Lead sponsor:** St. Luke's Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2001-01
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2013-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00016042

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00016042, "Fluorouracil and Biological Therapy in Treating Patients With Metastatic Kidney or Colorectal Cancer". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00016042. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*